IL-7: The global builder of the innate lymphoid network and beyond, one niche at a time

Seminars in Immunology

Volumn 24, Issue 3, 2012, Pages 190-197

  Kang, Joonsoo ^a   Coles, Mark ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Gammadelta T cells; Gut associated lymphoid tissues; IL 7 reporter mice; Innate lymphoid cells; Regulation of IL 7R expression; T cell development

Indexed keywords

ESTROGEN; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; JANUS KINASE 3; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOTOXIN; VASCULOTROPIN D;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; GENE TARGETING; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOTHERAPY; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; LYMPHOID CELL; MESENCHYME CELL; MICROENVIRONMENT; NONHUMAN; ORGANOGENESIS; POSTMENOPAUSE; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STROMA CELL;

ANIMALS; B-LYMPHOCYTES; CELL COMMUNICATION; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-7; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTES;

EID: 84861186619     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.02.003     Document Type: Review

References (125)

1. Namen A.E., Lupton S., Hjerrild K., Wignall J., Mochizuki D.Y., Schmierer A., et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988, 333:571-573.
2. Ye S.K., Agata Y., Lee H.C., Kurooka H., Kitamura T., Shimizu A., et al. The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation. Immunity 2001, 15:813-823.
3. Chowdhury D., Sen R. Transient IL-7/IL-7R signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrangements. Immunity 2003, 18:229-241.
4. Park J.H., Adoro S., Guinter T., Erman B., Alag A.S., Catalfamo M., et al. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol 2010, 11:257-264.
5. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000, 1:426-432.
6. Seddon B., Tomlinson P., Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003, 4:680-686.
7. Hand T.W., Morre M., Kaech S.M. Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection. Proc Natl Acad Sci U S A 2007, 104:11730-11735.
8. Malin S., McManus S., Busslinger M. STAT5 in B cell development and leukemia. Curr Opin Immunol 2010, 22:168-176.
9. Mazzucchelli R., Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007, 7:144-154.
10. Mackall C.L., Fry T.J., Gress R.E. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011, 11:330-342.
11. Sprent J., Surh C.D. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol 2011, 12:478-484.
12. Yamagata T., Benoist C., Mathis D. A shared gene-expression signature in innate-like lymphocytes. Immunol Rev 2006, 210:52-66.
13. Berg L.J. Signalling through TEC kinases regulates conventional versus innate CD8(+) T-cell development. Nat Rev Immunol 2007, 7:479-485.
14. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011, 12:21-27.
15. O'Brien R.L., Born W.K. gammadelta T cell subsets: a link between TCR and function?. Semin Immunol 2010, 22:193-198.
16. Satoh-Takayama N., Lesjean-Pottier S., Vieira P., Sawa S., Eberl G., Vosshenrich C.A., et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 2010, 207:273-280.
17. Vonarbourg C., Mortha A., Bui V.L., Hernandez P.P., Kiss E.A., Hoyler T., et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 2010, 33:736-751.
18. Schluns K.S., Klonowski K.D., Lefrancois L. Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells. Blood 2004, 103:988-994.
19. Burkett P.R., Koka R., Chien M., Chai S., Boone D.L., Ma A. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J Exp Med 2004, 200:825-834.
20. Baccala R., Witherden D., Gonzalez-Quintial R., Dummer W., Surh C.D., Havran W.L., et al. Gamma delta T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors. J Immunol 2005, 174:4606-4612.
21. French J.D., Roark C.L., Born W.K., O'Brien R.L. {gamma}{delta} T cell homeostasis is established in competition with {alpha}{beta} T cells and NK cells. Proc Natl Acad Sci U S A 2005, 102:14741-14746.
22. Bolotin E., Annett G., Parkman R., Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999, 23:783-788.
23. Zubkova I., Mostowski H., Zaitseva M. Up-regulation of IL-7, stromal-derived factor-1 alpha, thymus-expressed chemokine, and secondary lymphoid tissue chemokine gene expression in the stromal cells in response to thymocyte depletion: implication for thymus reconstitution. J Immunol 2005, 175:2321-2330.
24. Sawa Y., Arima Y., Ogura H., Kitabayashi C., Jiang J.J., Fukushima T., et al. Hepatic interleukin-7 expression regulates T cell responses. Immunity 2009, 30:447-457.
25. Kim G.Y., Hong C., Park J.H. Seeing is believing: illuminating the source of in vivo interleukin-7. Immune Netw 2011, 11:1-10.
26. Repass J.F., Laurent M.N., Carter C., Reizis B., Bedford M.T., Cardenas K., et al. IL7-hCD25 and IL7-Cre BAC transgenic mouse lines: new tools for analysis of IL-7 expressing cells. Genesis 2009, 47:281-287.
27. Borghesi L.A., Yamashita Y., Kincade P.W. Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis. Blood 1999, 93:140-148.
28. Li R., Paul A., Ko K.W., Sheldon M., Rich B.E., Terashima T., et al. Interleukin-7 induces recruitment of monocytes/macrophages to endothelium. Eur Heart J 2011, 10.1093/eurheart/ehr245.
29. Hoe E., McKay F.C., Schibeci S.D., Gandhi K., Heard R.N., Stewart G.J., et al. Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells. J Immunol 2010, 184:2512-2517.
30. Crawley A.M., Faucher S., Angel J.B. Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection. J Immunol 2010, 184:4679-4687.
31. Rane L., Rahman S., Magalhaes I., Ahmed R., Spangberg M., Kondova I., et al. Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue. Genes Immun 2011, 12:513-522.
32. McElroy C.A., Dohm J.A., Walsh S.T. Structural and biophysical studies of the human IL-7/IL-7Ralpha complex. Structure 2009, 17:54-65.
33. Pallard C., Stegmann A.P., van Kleffens T., Smart F., Venkitaraman A., Spits H. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 1999, 10:525-535.
34. Rathmell J.C., Farkash E.A., Gao W., Thompson C.B. IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 2001, 167:6869-6876.
35. Osborne L.C., Dhanji S., Snow J.W., Priatel J.J., Ma M.C., Miners M.J., et al. Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R alpha mutant mice. J Exp Med 2007, 204:619-631.
36. Rose T., Pillet A.H., Lavergne V., Tamarit B., Lenormand P., Rousselle J.C., et al. Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response. J Biol Chem 2010, 285:14898-14908.
37. Chappaz S., Flueck L., Farr A.G., Rolink A.G., Finke D. Increased TSLP availability restores T- and B-cell compartments in adult IL-7 deficient mice. Blood 2007, 110:3862-3870.
38. Rochman Y., Kashyap M., Robinson G.W., Sakamoto K., Gomez-Rodriguez J., Wagner K.U., et al. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Proc Natl Acad Sci U S A 2010, 107:19455-19460.
39. Yoshimura A., Naka T., Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007, 7:454-465.
40. Fujimoto M., Naka T., Nakagawa R., Kawazoe Y., Morita Y., Tateishi A., et al. Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice. J Immunol 2000, 165:1799-1806.
41. Chong M.M., Cornish A.L., Darwiche R., Stanley E.G., Purton J.F., Godfrey D.I., et al. Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity 2003, 18:475-487.
42. Kosan C., Saba I., Godmann M., Herold S., Herkert B., Eilers M., et al. Transcription factor miz-1 is required to regulate interleukin-7 receptor signaling at early commitment stages of B cell differentiation. Immunity 2010, 33:917-928.
43. Saba I., Kosan C., Vassen L., Moroy T. IL-7R-dependent survival and differentiation of early T-lineage progenitors is regulated by the BTB/POZ domain transcription factor Miz-1. Blood 2011, 117:3370-3381.
44. Yu Q., Xu M., Sen J.M. Beta-catenin expression enhances IL-7 receptor signaling in thymocytes during positive selection. J Immunol 2007, 179:126-131.
45. Rathinam C., Flavell R.A. c-Cbl deficiency leads to diminished lymphocyte development and functions in an age-dependent manner. Proc Natl Acad Sci U S A 2010, 107:8316-8321.
46. Lee A.J., Zhou X., Chang M., Hunzeker J., Bonneau R.H., Zhou D., et al. Regulation of natural killer T-cell development by deubiquitinase CYLD. Embo J 2010, 29:1600-1612.
47. Tian B., Nowak D.E., Jamaluddin M., Wang S., Brasier A.R. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. J Biol Chem 2005, 280:17435-17448.
48. Park J.H., Yu Q., Erman B., Appelbaum J.S., Montoya-Durango D., Grimes H.L., et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004, 21:289-302.
49. Purohit S.J., Stephan R.P., Kim H.G., Herrin B.R., Gartland L., Klug C.A. Determination of lymphoid cell fate is dependent on the expression status of the IL-7 receptor. Embo J 2003, 22:5511-5521.
50. Dengler H.S., Baracho G.V., Omori S.A., Bruckner S., Arden K.C., Castrillon D.H., et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 2008, 9:1388-1398.
51. Amin R.H., Schlissel M.S. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 2008, 9:613-622.
52. Lin Y.C., Jhunjhunwala S., Benner C., Heinz S., Welinder E., Mansson R., et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 2010, 11:635-643.
53. Munitic I., Williams J.A., Yang Y., Dong B., Lucas P.J., El Kassar N., et al. Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis. Blood 2004, 104:4165-4172.
54. Malin S., McManus S., Cobaleda C., Novatchkova M., Delogu A., Bouillet P., et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 2010, 11:171-179.
55. Singh H., Medina K.L., Pongubala J.M. Contingent gene regulatory networks and B cell fate specification. Proc Natl Acad Sci U S A 2005, 102:4949-4953.
56. Yu Q., Erman B., Park J.H., Feigenbaum L., Singer A. IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development. J Exp Med 2004, 200:797-803.
57. Kang J., Volkmann A., Raulet D.H. Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. J Exp Med 2001, 193:689-698.
58. Melichar H.J., Narayan K., Der S.D., Hiraoka Y., Gardiol N., Jeannet G., et al. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science 2007, 315:230-233.
59. Turchinovich G., Hayday A.C. Skint-1 identifies a common molecular mechanism for the development of interferon-gamma-secreting versus interleukin-17-secreting gammadelta T cells. Immunity 2011, 35:59-68.
60. Kerdiles Y.M., Beisner D.R., Tinoco R., Dejean A.S., Castrillon D.H., DePinho R.A., et al. Foxo1 links homing and survival of naive T cells by regulating l-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 2009, 10:176-184.
61. Xue H.H., Bollenbacher J., Rovella V., Tripuraneni R., Du Y.B., Liu C.Y., et al. GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells. Nat Immunol 2004, 5:1036-1044.
62. Fahl S.P., Crittenden R.B., Allman D., Bender T.P. c-Myb is required for pro-B cell differentiation. J Immunol 2009, 183:5582-5592.
63. DeKoter R.P., Schweitzer B.L., Kamath M.B., Jones D., Tagoh H., Bonifer C., et al. Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells. J Biol Chem 2007, 282:14194-14204.
64. Egawa T., Tillman R.E., Naoe Y., Taniuchi I., Littman D.R. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J Exp Med 2007, 204:1945-1957.
65. Grenningloh R., Tai T.S., Frahm N., Hongo T.C., Chicoine A.T., Brander C., et al. Ets-1 maintains IL-7 receptor expression in peripheral T cells. J Immunol 2011, 186:969-976.
66. Chandele A., Joshi N.S., Zhu J., Paul W.E., Leonard W.J., Kaech S.M. Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1. J Immunol 2008, 180:5309-5319.
67. Guo F., Hildeman D., Tripathi P., Velu C.S., Grimes H.L., Zheng Y. Coordination of IL-7 receptor and T-cell receptor signaling by cell-division cycle 42 in T-cell homeostasis. Proc Natl Acad Sci U S A 2010, 107:18505-18510.
68. Zhu J., Davidson T.S., Wei G., Jankovic D., Cui K., Schones D.E., et al. Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 2009, 206:329-341.
69. Yucel R., Karsunky H., Klein-Hitpass L., Moroy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med 2003, 197:831-844.
70. Doan L.L., Kitay M.K., Yu Q., Singer A., Herblot S., Hoang T., et al. Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment. J Immunol 2003, 170:2356-2366.
71. Gross D.N., van den Heuvel A.P., Birnbaum M.J. The role of FoxO in the regulation of metabolism. Oncogene 2008, 27:2320-2336.
72. Ouyang W., Beckett O., Flavell R.A., Li M.O. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 2009, 30:358-371.
73. Carlson C.M., Endrizzi B.T., Wu J., Ding X., Weinreich M.A., Walsh E.R., et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 2006, 442:299-302.
74. Feng X., Wang H., Takata H., Day T.J., Willen J., Hu H. Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat Immunol 2011, 12:544-550.
75. Possot C., Schmutz S., Chea S., Boucontet L., Louise A., Cumano A., et al. Notch signaling is necessary for adult, but not fetal, development of RORgammat(+) innate lymphoid cells. Nat Immunol 2011, 12:949-958.
76. Shibata K., Yamada H., Sato T., Dejima T., Nakamura M., Ikawa T., et al. Notch-Hes1 pathway is required for the development of IL-17-producing gammadelta T cells. Blood 2011, 118:586-593.
77. Yoshida H., Honda K., Shinkura R., Adachi S., Nishikawa S., Maki K., et al. IL-7 receptor alpha+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches. Int Immunol 1999, 11:643-655.
78. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008, 14:282-289.
79. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
80. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008, 29:947-957.
81. Sawa S., Cherrier M., Lochner M., Satoh-Takayama N., Fehling H.J., Langa F., et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010, 330:665-669.
82. Lochner M., Peduto L., Cherrier M., Sawa S., Langa F., Varona R., et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med 2008, 205:1381-1393.
83. Rachitskaya A.V., Hansen A.M., Horai R., Li Z., Villasmil R., Luger D., et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 2008, 180:5167-5171.
84. Coquet J.M., Chakravarti S., Kyparissoudis K., McNab F.W., Pitt L.A., McKenzie B.S., et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc Natl Acad Sci U S A 2008, 105:11287-11292.
85. Monticelli L.A., Yang Y., Knell J., D'Cruz L.M., Cannarile M.A., Engel I., et al. Transcriptional regulator Id2 controls survival of hepatic NKT cells. Proc Natl Acad Sci U S A 2009, 106:19461-19466.
86. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S., et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999, 397:702-706.
87. Carotta S., Pang S.H., Nutt S.L., Belz G.T. Identification of the earliest NK-cell precursor in the mouse BM. Blood 2011, 117:5449-5452.
88. Cella M., Otero K., Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci U S A 2010, 107:10961-10966.
89. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007, 8:967-974.
90. Brustle A., Heink S., Huber M., Rosenplanter C., Stadelmann C., Yu P., et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007, 8:958-966.
91. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
92. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
93. Saenz S.A., Siracusa M.C., Perrigoue J.G., Spencer S.P., Urban J.F., Tocker J.E., et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464:1362-1366.
94. Hurst S.D., Muchamuel T., Gorman D.M., Gilbert J.M., Clifford T., Kwan S., et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002, 169:443-453.
95. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
96. Mjosberg J.M., Trifari S., Crellin N.K., Peters C.P., van Drunen C.M., Piet B., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011, 12:1055-1062.
97. Reardon C., Lechmann M., Brustle A., Gareau M.G., Shuman N., Philpott D., et al. Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation. Immunity 2011, 35:223-235.
98. Meier D., Bornmann C., Chappaz S., Schmutz S., Otten L.A., Ceredig R., et al. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 2007, 26:643-654.
99. Luther S.A., Ansel K.M., Cyster J.G. Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J Exp Med 2003, 197:1191-1198.
100. Kim M.Y., Anderson G., White A., Jenkinson E., Arlt W., Martensson I.L., et al. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3-inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J Immunol 2005, 174:6686-6691.
101. Yoshida H., Naito A., Inoue J., Satoh M., Santee-Cooper S.M., Ware C.F., et al. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches. Immunity 2002, 17:823-833.
102. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009, 10:66-74.
103. Veiga-Fernandes H., Coles M.C., Foster K.E., Patel A., Williams A., Natarajan D., et al. Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis. Nature 2007, 446:547-551.
104. Honda K., Nakano H., Yoshida H., Nishikawa S., Rennert P., Ikuta K., et al. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J Exp Med 2001, 193:621-630.
105. Chappaz S., Finke D. The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes. J Immunol 2010, 184:3562-3569.
106. Park L.S., Martin U., Garka K., Gliniak B., Di Santo J.P., Muller W., et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000, 192:659-670.
107. Nishikawa S., Honda K., Vieira P., Yoshida H. Organogenesis of peripheral lymphoid organs. Immunol Rev 2003, 195:72-80.
108. Coles M.C., Veiga-Fernandes H., Foster K.E., Norton T., Pagakis S.N., Seddon B., et al. Role of T and NK cells and IL7/IL7r interactions during neonatal maturation of lymph nodes. Proc Natl Acad Sci U S A 2006, 103:13457-13462.
109. Dus D., Krawczenko A., Zalecki P., Paprocka M., Wiedlocha A., Goupille C., et al. IL-7 receptor is present on human microvascular endothelial cells. Immunol Lett 2003, 86:163-168.
110. Ming J., Zhang Q., Qiu X., Wang E. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. Eur J Cancer 2009, 45:866-873.
111. Ngom P.T., Collinson A.C., Pido-Lopez J., Henson S.M., Prentice A.M., Aspinall R. Improved thymic function in exclusively breastfed infants is associated with higher interleukin 7 concentrations in their mothers' breast milk. Am J Clin Nutr 2004, 80:722-728.
112. Aspinall R., Prentice A.M., Ngom P.T. Interleukin 7 from maternal milk crosses the intestinal barrier and modulates T-cell development in offspring. PLoS One 2011, 6:e20812.
113. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
114. Mourcin F., Breton C., Tellier J., Narang P., Chasson L., Jorquera A., et al. Galectin-1-expressing stromal cells constitute a specific niche for pre-BII cell development in mouse bone marrow. Blood 2011, 117:6552-6561.
115. Iwata M., Graf L., Awaya N., Torok-Storb B. Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein. Blood 2002, 100:1318-1325.
116. Pellegrini M., Calzascia T., Toe J.G., Preston S.P., Lin A.E., Elford A.R., et al. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 2011, 144:601-613.
117. Rihl M., Kellner H., Kellner W., Barthel C., Yu D.T., Tak P.P., et al. Identification of interleukin-7 as a candidate disease mediator in spondylarthritis. Arthritis Rheum 2008, 58:3430-3435.
118. Hartgring S.A., Willis C.R., Alcorn D., Nelson L.J., Bijlsma J.W., Lafeber F.P., et al. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum 2010, 62:2716-2725.
119. Weitzmann M.N., Roggia C., Toraldo G., Weitzmann L., Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002, 110:1643-1650.
120. Wittig O., Paez-Cortez J., Cardier J.E. Liver sinusoidal endothelial cells promote B lymphopoiesis from primitive hematopoietic cells. Stem Cells Dev 2010, 19:341-350.
121. Felices M., Yin C.C., Kosaka Y., Kang J., Berg L.J. Tec kinase Itk in gammadeltaT cells is pivotal for controlling IgE production in vivo. Proc Natl Acad Sci U S A 2009, 106:8308-8313.
122. Zuvich R.L., McCauley J.L., Oksenberg J.R., Sawcer S.J., De Jager P.L., Aubin C., et al. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet 2010, 127:525-535.
123. Levy Y., Lacabaratz C., Weiss L., Viard J.P., Goujard C., Lelievre J.D., et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 2009, 119:997-1007.
124. Liu X., Leung S., Wang C., Tan Z., Wang J., Guo T.B., et al. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med 2010, 16:191-197.
125. Nanjappa S.G., Walent J.H., Morre M., Suresh M. Effects of IL-7 on memory CD8 T cell homeostasis are influenced by the timing of therapy in mice. J Clin Invest 2008, 118:1027-1039.